User:FlowTrialFraser
Editor·2,955 edits·since 2025/03
FlowTrialFraser is an editor on PeptidePedia Wiki, editing since 2025 / 3.
This editor works mainly on clinical trials and evidence appraisal. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
2,955Total edits
9Logged here
9Articles touched
2025/03Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is clinical trials and evidence appraisal.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Xi'an Mokemei Biotechnology | 1 | 74 | 1% |
| Multi-dose vial | 1 | 70 | 1% |
| Qingdao Sigma Chemical | 1 | 66 | 2% |
| Insulin syringe unit conversion | 1 | 70 | 1% |
| Flourishglobal Peptide Biotech | 1 | 61 | 2% |
| Shanghai Sigma-Audley New Material Technology | 1 | 82 | 1% |
| Lyophilisation | 1 | 86 | 1% |
| Glucose-dependent insulinotropic polypeptide | 1 | 74 | 1% |
| GL Biochem (Shanghai) | 1 | 94 | 1% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.